Related by context. All words. (Click for frequent words.) 65 renin inhibitors 63 PS# [001] 62 Dapagliflozin 62 ISIS # 62 lomitapide 62 NVA# 62 atacicept 62 Mipomersen 61 Rasilez 60 metaglidasen 60 LAF# 60 Epanova 60 renin inhibitor 60 HuMax EGFr 60 TriRima 60 DPP4 inhibitor 60 elotuzumab 60 insulin sensitizing 60 Atacand 60 BAY #-# 60 methylnaltrexone 59 Panzem R 59 RLY# 59 INCB# [002] 59 daclizumab 59 riociguat 59 CBLC# 59 CORT # 59 QVA# 59 valsartan 59 Amrubicin 59 HuMax CD# 59 endothelin receptor antagonists 59 PRX # 58 Exforge HCT 58 MGCD# [001] 58 PF # [001] 58 EOquin 58 mipomersen 58 Archexin 58 direct renin inhibitor 58 PEG SN# 58 angiotensin receptor blocker ARB 58 alvespimycin 58 JAK inhibitor 58 pitavastatin 58 aleglitazar 58 ularitide 58 HuMax CD4 58 forodesine 58 deforolimus 58 Zerenex 58 Icatibant 58 vidofludimus 58 LY# [003] 58 AERx iDMS 58 fenofibric acid 58 ATL# [001] 58 olmesartan 58 diabetic nephropathy 58 insulin degludec 58 insulin sensitizers 58 diabetic neuropathic pain 58 Exenatide 58 Speedel 58 zileuton 57 xanthine oxidase inhibitor 57 ProSavin 57 oxymorphone ER 57 Nanobody 57 ulimorelin 57 oral prodrug 57 atrasentan 57 MBP# [001] 57 YONDELIS 57 muraglitazar 57 Tyrima 57 investigational compound 57 Exforge 57 indacaterol 57 ORMD 57 Syncria 57 aliskiren 57 SNT MC# 57 nebivolol 57 ocrelizumab 57 INT# [002] 57 EndoTAG TM -1 57 RhuDex ® 57 dirucotide 57 Plicera 57 tanespimycin 57 tamibarotene 57 TBC# 57 NGX# 57 EDARBI 57 Aliskiren 57 eniluracil 57 Liraglutide 57 insulin analogs 57 cediranib 57 metformin sulfonylurea 57 edoxaban 57 betrixaban 57 Triolex 57 Traficet EN 57 PSN# [002] 57 AEG# 57 enzastaurin 57 seliciclib CYC# 57 albiglutide 57 6R BH4 57 exenatide 57 pradefovir 57 MB# [004] 57 ASA# 56 Oglemilast 56 COREG CR 56 PROMACTA 56 ISTODAX 56 BCX# 56 Golimumab 56 fenofibrate 56 Onbrez Breezhaler 56 Darusentan 56 Azedra 56 Orazol 56 angiogenesis inhibitor 56 selective modulator 56 tolerability profiles 56 Dasatinib 56 Tekturna 56 omecamtiv mecarbil 56 BYDUREON 56 Sym# 56 Naproxcinod 56 GFT# 56 selective androgen receptor modulator 56 Phase Ib 56 AQ4N 56 HIV integrase inhibitor 56 lumiliximab 56 SAR# [004] 56 bardoxolone 56 Ambrisentan 56 talactoferrin 56 teriflunomide 56 Candesartan 56 oral renin inhibitor 56 Phase 2b 56 tolvaptan 56 pramlintide 56 Phase IIIb clinical 56 tocilizumab 56 Synavive 56 MEK inhibitor 56 Starlix 56 favorable pharmacokinetic profile 56 PRT# 56 dyslipidemia 56 aclidinium bromide 56 Targretin 56 Ostarine 56 Rasilez Tekturna 56 Safinamide 56 JANUVIA 56 ATL/TV# 56 otelixizumab 56 sitagliptin 56 severe hypercholesterolemia 56 ganetespib 56 fluticasone furoate 56 eprotirome 56 liposomal formulation 56 sodium glucose cotransporter 56 SARMs 56 generation purine nucleoside 56 Balaglitazone 56 TRIOLEX 56 TREDAPTIVE 56 PEG Interferon lambda 56 XL# XL# XL# XL# 56 Phase 2b clinical 56 PXD# 56 Atrasentan 56 custirsen 56 Phase #b/#a 56 Saxagliptin 56 darusentan 56 Tekamlo 56 PSMA ADC 56 Dacogen injection 56 DU #b 56 Relovair 56 Adentri 56 ALN PCS 56 Guanilib 56 ambrisentan 56 VEGF Trap 56 Panzem 55 TELINTRA 55 Bicifadine 55 Virulizin R 55 Genz # 55 orally administered inhibitor 55 Desmoteplase 55 TACI Ig 55 vildagliptin 55 ELACYT 55 aclidinium 55 LY# [002] 55 Tamibarotene 55 darapladib 55 CTAP# Capsules 55 febuxostat 55 SGLT2 inhibitor 55 HCV protease inhibitor 55 calcineurin inhibitors 55 NXL# 55 rNAPc2 55 DCCR 55 Telmisartan 55 phase IIb 55 AP# [003] 55 esomeprazole Nexium 55 HGS# 55 Taspoglutide 55 veltuzumab 55 BAL# [002] 55 cannabinor 55 incyclinide 55 aplindore 55 Symadex 55 thiazolidinediones TZDs 55 FTY# 55 Ventavis 55 novel VDA molecule 55 phase IIb clinical 55 oral rivaroxaban 55 INCB# [001] 55 Asentar 55 eltrombopag 55 subcutaneous formulation 55 amrubicin 55 Vidofludimus 55 Ocrelizumab 55 Ceflatonin 55 phase IIa clinical 55 BYETTA ® 55 Febuxostat 55 TWYNSTA ® 55 AZILECT R 55 OXi# 55 nitric oxide donating prostaglandin 55 ADX# 55 Tarceva TM 55 R#/MEM # 55 Pimavanserin 55 relapsed multiple myeloma 55 Chemophase 55 XL# [003] 55 phase Ib 55 Pazopanib 55 Lodotra 55 Gabapentin GR 55 DPP4 55 RDEA# 55 Tanespimycin 55 gastrin 55 Heplisav 55 canakinumab 55 danoprevir 55 INCB# [003] 55 pramlintide metreleptin 55 phase IIb trial 55 Phase 2a trial 55 Xanafide 55 Muraglitazar 55 perifosine 55 PDE4 inhibitor 55 CIMZIA ™ 55 fostamatinib 55 RhuDex 55 Byetta exenatide 55 ruxolitinib 55 nalbuphine ER 55 iniparib 55 Cycloset 55 linaclotide 55 OvaRex ® MAb 55 Actemra 55 Stedivaze 55 zalutumumab 55 Sitagliptin 55 Marqibo 55 Rivaroxaban 54 fluvastatin 54 GALNS 54 ELND# 54 DB# [003] 54 Caduet 54 TRILIPIX 54 CR# vcMMAE 54 JAK3 inhibitor 54 Alvesco R 54 Valsartan 54 Vernakalant 54 rilonacept 54 Phase 2a clinical 54 antidiabetic drugs 54 urocortin 2 54 oral antidiabetic 54 Amigal 54 SRT# [003] 54 HFA MDI 54 Tolvaptan 54 RSD# oral 54 alvimopan 54 ARIKACE 54 ozarelix 54 APD# 54 motesanib 54 fosbretabulin 54 QLT# 54 Alfimeprase 54 fibrate 54 glitazones 54 visilizumab 54 investigational drug 54 cMET 54 Phase Ib study 54 Aviptadil 54 APTIVUS r 54 antiplatelet agent 54 Phase 2a 54 mixed dyslipidemia 54 hypercholesterolemia 54 PHX# 54 safinamide 54 Laquinimod 54 candesartan cilexetil 54 Bortezomib 54 nonclinical studies 54 ATL# [002] 54 regadenoson 54 lixisenatide 54 synthetic retinoid 54 Phase IIa 54 IFN α 54 Promacta 54 QAB# 54 Abiraterone acetate 54 entacapone 54 Aptivus ® 54 VAPRISOL 54 HCD# [002] 54 aflibercept 54 Pioglitazone 54 vernakalant 54 oral cladribine 54 AEGR 54 compound INCB# 54 Protelos 54 Vicriviroc 54 Eltrombopag 54 JAK1 54 SERCA2a 54 pioglitazone Actos 54 antisense drug 54 Neulasta ® 54 regorafenib 54 XL# XL# XL# 54 alfimeprase 54 triglyceride lowering 54 Debio 54 ABILIFY ® 54 taspoglutide 54 Certriad 54 epothilone 54 Diovan 54 Victoza liraglutide 54 Kuvan 54 Serdolect ® 54 Glargine 54 dacetuzumab 54 CIMZIA TM 54 tolerability profile 54 Phenoptin 54 GAMMAGARD 54 bicifadine 54 Cleviprex TM clevidipine 54 HoFH 54 pertuzumab 54 MEK inhibitors 54 tesetaxel 54 QNEXA 54 PSN# [001] 54 TREANDA 54 R#/MEM 54 Pivotal Phase III 54 taranabant 54 investigational protease inhibitor 54 Remicade infliximab 54 PNP inhibitor 54 administered subcutaneously 54 inhaled formulation 54 HCV polymerase inhibitors 54 allosteric modulator 54 zanolimumab 54 LCP Tacro 54 brivaracetam 54 PRISTIQ 54 panitumumab Vectibix 54 Belinostat 54 Torisel 54 TPI ASM8 54 ApoB SNALP 54 teplizumab 54 PDE4 inhibitors 54 adalimumab Humira 54 RELOVAIR ™ 54 neratinib 54 cathepsin K inhibitor 54 albinterferon alfa 2b 54 Troxatyl 54 cilengitide 53 dosing cohort 53 CD# antibody [001] 53 LAS# [002] 53 registrational trial 53 Panzem R NCD 53 Zolinza 53 MoxDuo IR 53 MIRCERA 53 Lodotra TM 53 SGLT2 53 treprostinil 53 phase IIa 53 interferon gamma 1b 53 anticancer agent 53 immunotherapeutic agent 53 Cetrorelix 53 Rebif ® 53 Perindopril 53 TriLipix 53 GSK# [001] 53 Sutent sunitinib 53 Pirfenidone 53 factor Xa inhibitor 53 Stimuvax R 53 Toviaz 53 TRV# [001] 53 Apoptone 53 ANAVEX #-# [003] 53 alagebrium 53 antiarrhythmic 53 IMGN# 53 Revlimid lenalidomide 53 Technosphere Insulin 53 ORENCIA R 53 Avastin bevacizumab 53 torezolid phosphate 53 HCV protease inhibitors 53 LymphoStat B 53 davalintide 53 Actos pioglitazone 53 trospium 53 ThGRF 53 celgosivir 53 decitabine 53 irbesartan 53 Lantus ® 53 Valdoxan 53 Fulvestrant 53 insulin sensitizer 53 UVIDEM 53 DG# [001] 53 exenatide LAR 53 ADVANCE PD 53 Velcade bortezomib 53 Solulin 53 #ME# 53 rFVIIIFc 53 ofatumumab 53 aldosterone antagonists 53 Aptivus 53 liprotamase 53 active comparator 53 glitazone 53 PCK# 53 bortezomib Velcade 53 peroxisome proliferator activated 53 Phase IIa clinical 53 Phase IIa trials 53 thiazolidinedione 53 CINQUIL 53 CCR9 antagonist 53 Levemir ® 53 Phase IIa clinical trials 53 losartan Cozaar 53 formoterol fumarate 53 MAP# 53 IAP inhibitor 53 RSD# 53 carfilzomib 53 roflumilast 53 palonosetron 53 aripiprazole Abilify 53 Tasimelteon 53 Prestara 53 Vitaxin 53 AERx 53 milnacipran 53 oral anticoagulant 53 Phase 2a Clinical Trial 53 Everolimus 53 SYMBICORT 53 Lantus insulin 53 anti arrhythmic 53 antithrombotic 53 thiazolidinediones 53 sitaxsentan 53 Recombinant Human 53 SILENOR 53 receptor antagonist 53 pomalidomide 53 budesonide 53 casopitant 53 Benicar 53 Nanobodies 53 AZILECT 53 NN# [001] 53 MAXY alpha 53 TAFA# 53 talabostat 53 Phase IIb trials 53 Catena ® 53 Boceprevir 53 evaluating tivozanib 53 Roche Actemra 53 IRX 2 53 rufinamide 53 Rasilez ® 53 Imprime PGG 53 oral methylnaltrexone 53 maximally tolerated dose 53 AZD# 53 EndoTAG TM 53 MDV# 53 Virulizin ® 53 L BLP# 53 tezampanel 53 axitinib 53 opioid induced bowel dysfunction 53 Aflibercept 53 Locteron ® 53 radezolid 53 Perifosine 53 elesclomol 53 APOPTONE 53 Qnexa 53 CYCLOSET 53 ICA # 53 ramelteon 53 Phase 1b 53 selective COX 2 53 pegylated interferons 53 insulin detemir 53 favorable tolerability 53 odanacatib 53 preclinical efficacy 53 Genasense ® oblimersen 53 JAK2 inhibitor 53 FM VP4 53 Androxal TM 53 mGluR2 NAM 53 PEG PAL 53 Phase IIb trial 53 GLPG# 53 Aclidinium 53 Reverset 53 Phase Ib II 53 efficacy tolerability 53 SIMCOR 53 Civacir 53 LCP AtorFen 53 investigational oral 53 Lupuzor 53 urate lowering 53 tesofensine 53 TH# [003] 53 Degludec 53 ALN VSP 53 Nanobody ® 53 Revimmune 53 Lubiprostone 53 Bydureon 53 Aceon 53 preclinical 53 tiapamil 53 metoprolol succinate 53 ACTEMRA TM 53 NKTR 53 KRN# 53 COREG 53 receptor antagonists 53 SPC# [001] 53 APPRAISE 53 HQK 53 MAGE A3 ASCI 53 EGS# 53 Phase IIb clinical trials 53 teduglutide 53 ACE inhibitor ramipril 53 rFIXFc 53 PREOS R 53 midstage clinical 53 Annamycin 53 mapatumumab 53 Raptiva ® 53 vascular disrupting agent 53 PRTX 52 refractory gout 52 Arixtra 52 ® pioglitazone HCl 52 obatoclax 52 Milnacipran 52 Rasagiline 52 Azilect ® 52 Inhalation Solution 52 LEP ETU 52 Elesclomol 52 PLK1 SNALP 52 ridaforolimus 52 IDX# 52 Serdaxin 52 Adlea 52 temsirolimus 52 virus HCV protease inhibitor 52 Phase IIa trial 52 Rosiglitazone 52 azilsartan medoxomil 52 laninamivir 52 MLN# 52 placebo controlled Phase 52 Randomized Phase 52 zonisamide SR 52 Azixa 52 docetaxel Taxotere R 52 ASONEP 52 Aplidin 52 perampanel 52 faropenem 52 Afatinib 52 LHRH antagonists 52 mertansine 52 velafermin 52 nucleoside reverse transcriptase inhibitor 52 DYNEPO 52 Hsp# inhibitor 52 5 HT3 receptor 52 Empatic 52 FTY# fingolimod 52 pantoprazole 52 monotherapy 52 C1 INH 52 Hematide 52 Xarelto rivaroxaban 52 Losartan 52 proteasome inhibitors 52 BENICAR HCT 52 CCX# 52 Cinquil 52 lorcaserin 52 pharmacokinetic PK 52 RGB # 52 dalbavancin 52 Ticagrelor 52 exenatide once 52 orally administered 52 Trilipix 52 Tasigna nilotinib 52 Tekturna HCT 52 ruboxistaurin 52 Xinlay 52 Pruvel 52 mTOR inhibitor 52 MTP inhibitor 52 Exherin TM 52 receptor agonist 52 TRO# 52 sorafenib tablets 52 Bezielle 52 Taxotere docetaxel 52 Tracleer r 52 pioglitazone HCl 52 prescribed proton pump 52 bifeprunox 52 Vidaza azacitidine 52 Emselex 52 Targretin capsules 52 ADP receptor antagonist 52 SinuNase TM 52 Advagraf 52 TELCYTA 52 Hsp# inhibitors 52 SLx 52 alogliptin 52 NOXAFIL 52 Gemzar ® 52 heterozygous FH 52 phase 2a 52 ELIQUIS 52 TRX1 52 Arikace 52 tremelimumab 52 sorafenib Nexavar 52 Benlysta belimumab 52 PKC# 52 Phase III clinical 52 PEG INTRON 52 Phase 2b study 52 oral antidiabetic medication 52 ELADUR 52 omacetaxine 52 ZOLINZA 52 insulin analogues 52 Tredaptive 52 linagliptin 52 Perforomist ™ Inhalation Solution 52 lupus nephritis 52 AVANDIA 52 Phase Ib clinical trials 52 ENMD # 52 reslizumab 52 SELZENTRY 52 Quinamed 52 intranasal formulation 52 crizotinib PF # 52 Hsp# Inhibitor 52 APEX PD 52 VIAject 52 Factor VIIa 52 ACOMPLIA R 52 statin simvastatin 52 Phase 2b trial 52 MK #B 52 iclaprim 52 Ofatumumab 52 Dalbavancin 52 Bystolic 52 VA# [002] 52 Mycamine 52 demonstrated antitumor activity 52 investigational humanized monoclonal antibody 52 PROSTVAC TM 52 ENBREL 52 Alpharadin 52 Galvus 52 atypical antipsychotic 52 Coreg CR 52 AKT inhibitor 52 thymalfasin 52 basal insulin analogue 52 ACTEMRA 52 AMR# 52 GKAs 52 preclinical studies 52 2 methoxyestradiol 52 JAK inhibitors 52 CEQ# 52 rilpivirine 52 Unit Dose Budesonide 52 Roflumilast 52 IMiDs 52 liraglutide 52 bafetinib 52 dimebon 52 epigenetic therapies 52 BRIM2 52 motavizumab 52 Onco TCS 52 SPIRIVA HandiHaler 52 Anacetrapib 52 almorexant 52 Pramlintide 52 dose cohorts 52 Aurora kinase 52 Fortovase 52 Locteron 52 GRN#L 52 Behcet uveitis 52 MabThera rituximab 52 pan HDAC inhibitor 52 Bucindolol 52 Zometa zoledronic acid 52 Daliresp 52 AZILECT ® 52 Cloretazine R VNP#M 52 insulin glargine 52 midstage trials 52 catheter occlusion 52 Uloric 52 INC# 52 bazedoxifene 52 elinogrel 52 oral proteasome inhibitor 52 Tezampanel 52 Fx #A 52 rosuvastatin calcium 52 primary hypercholesterolemia 52 MERLIN TIMI 52 Pertuzumab 52 ixabepilone 52 epoetin 52 BENLYSTA 52 GRNCM1 52 Erbitux cetuximab 52 Tracleer R 52 Sular 52 XL# SAR# 52 telomerase therapeutic 52 Onconase 52 AZOR 52 pharmacokinetic PK profile 52 refractory CLL 52 molecularly targeted 52 vandetanib 52 Vfend 52 elvitegravir 52 receptor tyrosine kinase inhibitor 52 Akt inhibitor 52 GV# [001] 52 SCH # 52 Phase 2b clinical trials 52 idarubicin 52 Avandia rosiglitazone 52 ARCOXIA 52 epothilones 52 OMP #M# 52 davunetide 52 pharmacodynamic PD 52 anticancer compound 52 Blinatumomab 52 Viprinex 51 AVE# 51 SinuNase 51 EVIZON 51 Linaclotide 51 Crestor rosuvastatin 51 Chrysalin 51 XL# anticancer compounds 51 IMA# 51 orally bioavailable 51 Perforomist TM Inhalation Solution 51 ponatinib 51 AOD# [002] 51 Lisofylline 51 Santhera 51 PhosLo 51 TLK# 51 MAXY G# 51 Sanctura XR 51 R roscovitine 51 QNEXA ® 51 RoActemra 51 Epratuzumab 51 histone deacetylase HDAC inhibitor 51 Herceptin trastuzumab 51 ICS LABA 51 bapineuzumab 51 iSONEP 51 molecular entities NMEs 51 Bepreve 51 valopicitabine 51 ibandronate 51 tarenflurbil 51 proteasome inhibitor 51 REMICADE ® 51 TOLAMBA 51 levodopa carbidopa 51 CXB# 51 posaconazole 51 Contrave 51 confirmatory Phase III 51 CytoFab 51 sapacitabine 51 CCX# B 51 fingolimod 51 peginesatide 51 TKM ApoB 51 docetaxel Taxotere ® 51 ALGRX 51 pioglitazone 51 LIALDA 51 Nexavar ® 51 Metformin GR 51 HuLuc# 51 XmAb# 51 Methylnaltrexone 51 corticosteroid dexamethasone 51 Pivotal Phase 51 ALVESCO HFA 51 huC# DM4 51 Proquin XR 51 OncoVEX GM CSF 51 AZX# 51 Miraxion 51 pharmacodynamic 51 Rezular 51 Sapacitabine 51 anti amnesic 51 Zebinix R 51 Virulizin 51 Zenvia Phase III 51 Onalta 51 Zalbin 51 statin medications 51 Roche Xeloda 51 MYDICAR ® 51 Nasulin 51 sunitinib 51 terlipressin 51 Zenapax 51 IGIV 51 NovoRapid 51 Xibrom 51 EOquin TM 51 valsartan Diovan 51 pegylated 51 levosimendan 51 adecatumumab 51 golimumab 51 subcutaneously administered 51 SERMs 51 Factive 51 Phase III trials 51 IAP inhibitors 51 ALN TTR# 51 Arranon 51 CD# CEA 51 Phase III 51 Phase III clinical trials 51 ONTAK 51 Lisofylline LSF 51 LibiGel Phase III 51 Phase 1a clinical 51 Multaq R 51 Exelixis compounds 51 olaparib 51 Interferon beta 1a 51 guanfacine extended release 51 Tesofensine 51 Exelixis XL# 51 TYZEKA 51 dronedarone 51 PEP# [003] 51 tofacitinib 51 torcetrapib atorvastatin 51 generation antisense 51 oral ridaforolimus 51 BLA filing 51 Glypromate 51 pseudobulbar affect PBA 51 Satraplatin 51 Elagolix 51 MICARDIS ® 51 abatacept Orencia 51 novel anticancer 51 BrachySil TM 51 Sular formulation 51 glatiramer acetate 51 Huntexil 51 Genentech Roche 51 nucleoside analog 51 degludec 51 ACZ# 51 CA4P 51 Adalimumab 51 dose escalation Phase 51 Nuvion 51 TEMODAL 51 Celebrex celecoxib 51 adalimumab 51 ALN TTR 51 interferon beta 1b 51 CDP# 51 Remodulin 51 huN# DM1 51 Sanvar 51 glufosfamide 51 mGluR5 negative 51 Nexavar sorafenib 51 Auxilium Pharma 51 nab paclitaxel 51 intravenous dosing 51 acyclovir Lauriad R 51 Proellex 51 Omacetaxine